For most commuters hustling through Boston’s MBTA tunnels, Chicago’s labyrinthine corridors, or the glassy speedways of Orlando’s Brightline, digestive worries might seem like yesterday’s lunch. Yet, November 2025 finds a new contender vying for attention amid the ads for luxury watches and…
The recent groundbreaking at Wyoming’s Brook Mine marks a seismic shift in America’s approach to securing vital raw materials for defense and technology, as Ramaco Resources (METC) launched the first new U.S. rare earth element (REE) mine in over 70 years. This…
Lovable, the Stockholm-based AI coding platform, is making headlines after closing in on eight million users and securing a remarkable $228 million in funding—surely enough pocket change to keep the espresso machines humming for every developer north of Berlin. In a market…
Stocks soared Monday, November 10, 2025, with a rally that could make even the most seasoned bear consider a hibernation sabbatical. Wall Street’s major indexes leapt as Congress inched closer to ending the record-breaking government shutdown, unleashing the kind of risk-on mood…
Navitas Semiconductor (NVTS, $9.58, +22.19% currently on Monday) turned up the voltage on Wall Street’s risk tolerance last week, announcing a $100 million private placement that, if nothing else, once again proves the semiconductor crowd is not afraid to mix science with…
Cogent Biosciences (COGT) and GeoVax Labs (GOVX) offered investors and clinicians fresh cause for cautious celebration this week, both releasing data-laden news that—if not quite cocktail-hour material—could at least liven up a Monday earnings call with a smidgen of biotech bravado.…
Pfizer, never one to miss a raucous game of pharmaceutical musical chairs, has outmaneuvered Novo Nordisk in a $10 billion dash for Metsera, a company that—at the time of acquisition—boasted more promising obesity drugs in its pipeline than products on pharmacy shelves.…
Wall Street’s week wrapped with less of a bow and more of a sigh, as major indexes retreated under a cloud of AI valuation skepticism, limp labor data, and Capitol Hill’s existential drama over the government shutdown, which cost the economy an…
A consortium of 20 major banks has just written an $18 billion check—no, that’s not a misprint—to help underwrite Oracle’s (ORCL) latest ambition: a sprawling data center campus in New Mexico that promises to give even the most jaded AI skeptic a…
JFrog’s (FROG) third-quarter 2025 performance was anything but amphibious—unless “leaping” counts. The company vaulted past Wall Street forecasts, croaking out revenue of $139.6 million, soaring 26% year-over-year and leaving analysts' modest predictions somewhere in the lily pads. Investors had reason to rejoice;…
